Table 1.
Clinical characteristics of patient groups with synucleinopathy and control subjects.
| Parameter | MSA-P | PD | PAF | Control |
|---|---|---|---|---|
| Age | 59.7 ± 1.7 | 61.4 ± 2.3 | 63.2 ± 3.1 | 52.6 ± 1.9 |
| Sex (M/F) | 21/11 | 14/10 | 12/6 | 17/15 |
| Motor Onset Age, years | 53.8 ± 1.9 | 58.2 ± 2.3 | N/A | N/A |
| Anosmia | 13% | 71% | 22% | 20% |
| Dec. myocardial 18F-DA | 6.5% | 75% | 94% | 3% |
| Bradykinesia | 90% | 92% | 20% | 28% |
| Cogwheel Rigidity | 56% | 78% | 0% | 18% |
| Constipation | 68% | 70% | 83% | 50% |
| Decreased Sweating | 33% | 38% | 67% | 33% |
| Dementia | 12% | 44% | 0% | 28% |
| Depression | 43% | 58% | 33% | 50% |
| Erectile Failure in Men | 91% | 62% | 75% | 56% |
| Levodopa Responsive | 50% | 64% | N/A | 33% |
| Resting Tremor | 19% | 58% | 0% | 28% |
| Slurred Speech | 63% | 24% | 0% | 17% |
| Urinary Symptoms | 92% | 91% | 67% | 83% |